This episode from the 2022 Midyear Clinical Meeting discusses the current methodologies used in identifying COVID-19 and how pharmacists can evaluate commercial genetic tests used in identifying respiratory pathogens and antibiotic-resistant markers.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.